Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment OSW Q1 2026 Earnings EPS Beats Estimates with 389 Surprise Amid Modest Stock Decline Sweetgreen Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement MNST Q1 2026 Earnings EPS Beats Estimates by 83 Stock Edges Higher CPRI Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss